However, studies performed in cancer cells and in mice indicate that SIRT1 is also essential for maintenance of genomic stability, tumour suppression and DNA repair.4, 58 Thus, it could be challenging in the future to define conditions to pharmacologically modulate SIRT1 function in such a manner that it will be beneficial for cancer therapy. The gene discussed is SIRT1; the disease is neoplasm.